SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 278 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $271,729 | -3.0% | 2,097 | -17.1% | 0.02% | -5.6% |
Q3 2022 | $280,000 | +27.9% | 2,529 | +96.5% | 0.02% | +125.0% |
Q4 2020 | $219,000 | +21.0% | 1,287 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $181,000 | -13.8% | 1,287 | -1.6% | 0.01% | -20.0% |
Q2 2020 | $210,000 | -7.9% | 1,308 | -26.0% | 0.01% | +11.1% |
Q4 2019 | $228,000 | -95.3% | 1,767 | -95.7% | 0.01% | -95.4% |
Q1 2019 | $4,868,000 | -20.8% | 40,842 | -27.4% | 0.20% | -32.1% |
Q4 2018 | $6,143,000 | -82.4% | 56,292 | -73.9% | 0.29% | -75.6% |
Q3 2018 | $34,869,000 | +8.1% | 215,894 | -11.5% | 1.18% | +0.9% |
Q2 2018 | $32,250,000 | +33.2% | 243,985 | -25.3% | 1.17% | +23.1% |
Q1 2018 | $24,208,000 | -38.0% | 326,742 | -53.4% | 0.95% | -38.8% |
Q4 2017 | $39,016,000 | +20.0% | 701,228 | -2.2% | 1.55% | +14.5% |
Q3 2017 | $32,513,000 | +42.2% | 716,772 | +5.7% | 1.36% | +35.9% |
Q2 2017 | $22,864,000 | +27.8% | 678,270 | +12.2% | 1.00% | +21.9% |
Q1 2017 | $17,892,000 | +62.1% | 604,467 | +50.2% | 0.82% | +55.5% |
Q4 2016 | $11,041,000 | -32.5% | 402,525 | +51.2% | 0.53% | -36.8% |
Q3 2016 | $16,353,000 | +247.1% | 266,295 | +7.8% | 0.83% | +215.2% |
Q2 2016 | $4,712,000 | -54.6% | 247,086 | -23.5% | 0.26% | -61.1% |
Q3 2015 | $10,371,000 | +29.3% | 322,970 | +22.6% | 0.68% | +9.5% |
Q2 2015 | $8,019,000 | +74.6% | 263,520 | +21.1% | 0.62% | +40.9% |
Q3 2014 | $4,593,000 | -31.0% | 217,693 | -2.6% | 0.44% | -28.1% |
Q2 2014 | $6,656,000 | +52.3% | 223,433 | +22.9% | 0.61% | +46.4% |
Q1 2014 | $4,370,000 | -55.1% | 181,854 | -57.9% | 0.42% | -28.1% |
Q4 2013 | $9,727,000 | -42.4% | 432,418 | +20.9% | 0.58% | -50.2% |
Q3 2013 | $16,892,000 | +149.4% | 357,668 | +100.9% | 1.17% | +1.7% |
Q2 2013 | $6,772,000 | – | 178,034 | – | 1.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
IMS Capital Management | 32,215 | $774,000 | 0.91% |
Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |